Mark L. Collins
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- DNA and Nucleic Acid Chemistry 5
- Advanced biosensing and bioanalysis techniques 5
- Molecular Biology Techniques and Applications 4
- RNA regulation and disease 2
-
- Hepatitis B Virus Studies 6
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Carlos Santiago (2 shared papers)Lee F. Johnson (2 shared papers)Norah A. Terrault (4 shared papers)Teresa L. Wright (3 shared papers)Janice A. Kolberg (4 shared papers)Jill Detmer (4 shared papers)C. C. Chang (1 shared paper)Mário Guimarães Pessôa (2 shared papers)
- Journals
- Analytical Biochemistry (3 papers)Journal of Medical Virology (2 papers)Hepatology (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Mark L. Collins
15 papers receiving 797 citations
Peers
Comparison fields: 5 of 90
- Hepatology 159
- Virology 94
- Infectious Diseases 158
- Epidemiology 196
- Molecular Biology 417
Countries citing papers authored by Mark L. Collins
This map shows the geographic impact of Mark L. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Collins more than expected).
Fields of papers citing papers by Mark L. Collins
This network shows the impact of papers produced by Mark L. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Collins. The network helps show where Mark L. Collins may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark L. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 260 | |
| 2 | 1985 | 142 | |
| 3 | 1998 | 97 | |
| 4 | 1984 | 67 | |
| 5 | 1989 | 50 | |
| 6 | 1995 | 48 | |
| 7 | 1997 | 45 | |
| 8 | 2017 | 36 | |
| 9 | 1989 | 31 | |
| 10 | 1989 | 22 | |
| 11 | 1997 | 22 | |
| 12 | 1998 | 21 | |
| 13 | 1983 | 9 | |
| 14 | 2003 | 2 | |
| 15 | 1997 | 2 | |
| 16 | 2003 | 0 |
About Mark L. Collins
Mark L. Collins is a scholar working on Molecular Biology, Epidemiology, Hepatology, Infectious Diseases and Virology, having authored 16 papers that have together received 854 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers), DNA and Nucleic Acid Chemistry (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Molecular Biology Techniques and Applications (4 papers), RNA regulation and disease (2 papers) and Pesticide Residue Analysis and Safety (1 paper). The work is most often cited by research in Hepatology (159 citations), Virology (94 citations), Infectious Diseases (158 citations), Epidemiology (196 citations) and Molecular Biology (417 citations). Mark L. Collins has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Carlos Santiago, Lee F. Johnson, Norah A. Terrault, Teresa L. Wright, Janice A. Kolberg, Jill Detmer, C. C. Chang, Mário Guimarães Pessôa, Thomas Horn and Howayda M. Hassoba. Their work appears in journals such as Analytical Biochemistry, Journal of Medical Virology, Hepatology, Journal of Pharmaceutical and Biomedical Analysis and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.